ARK Investment Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
ARK Investment Management's BLUE Position: Q4 2019 in Review
ARK Investment Management sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 3,103 shares — an estimated $3.69M sold.
ARK Investment Management first reported a position in BLUE in Q4 2016 and held it in 12 quarters. The position peaked at $58.5M in Q3 2018. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.
- ARK Investment Management reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
- ARK Investment Management sold 3,103 bluebird bio shares in Q4 2019, an estimated $3.69M.
- ARK Investment Management first reported a position in bluebird bio in Q4 2016 and held it in 12 quarters.
- ARK Investment Management's bluebird bio position peaked at $58.5M in Q3 2018.
- 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.
Based on ARK Investment Management's 13F filing for Q4 2019, filed 31 Jan 2020.